Skip to main content
. 2023 Mar 22;44(5):1014–1022. doi: 10.1007/s00246-023-03134-9

Table 1.

Baseline characteristics, early cFO (at 72 h)

Demographics cFO < 5% (N = 59) cFO > 10% (N = 14) P-value
Age at OHT, years (mean, sd) 9.9 (7.0) 5.3 (6.2) 0.03
Infant < 1 year at OHT 12 (20.3%) 4 (28.6%) 0.5
Gender
 Male 30 (50.9%) 6 (42.9%) 0.59
 Female 29 (49.2%) 8 (57.1%)
Race
 Hispanic 33 (55.9%) 8 (57.1%) 0.94
 Weight, kg (mean, sd) 38.9 (27.7) 19.4 (19.4) 0.01
 Cyanotic lesion 14 (23.7%) 7 (50%) 0.05
Indications for transplant
 Congenital 12 (20.3%) 7 (50%) 0.08
 Myocarditis 2 (3.4%) 1 (7.1%)
 Cardiomyopathy 38 (64.4%) 4 (28.6%)
 Re-transplant failure 7 (11.9%) 2 (14.3%)
Support at transplant
 VAD 14 (23.7%) 2 (14.3%) 0.44
 ECLS 5 (8.5%) 0 (0%) 0.26
 Vasoactives 8 (13.6%) 1 (7.1%) 0.51
Peri/post-transplant
 Cardiopulmonary bypass (min) (mean, sd) 113.7 (59.8) 108.5 (31.5) 0.75
 Aortic cross-clamp (min) (mean, sd) 68.7 (33.0) 68.1 (31.5) 0.95
 Donor ischemic (min) (mean, sd) 194.3 (90.7) 199.5 (122.0) 0.87
 Max VIS 72H (mean, sd) 12.0 (5.2) 17.4 (13.5) 0.25
 Graft failure/postoperative ECLS 3 (5.1%) 4 (28.6%) 0.01

Bold values indicate statistical significance (p ≤ 0.05)

Baseline perioperative characteristics of patients with early postoperative cumulative fluid overload (cFO) assessed as cumulative fluid balance up to 72 h following post-cardiac transplantation, compared to those without postoperative cFO at given time period

OHT orthotopic heart transplant, VAD ventricular assist device, ECLS extracorporeal life support, VIS vasoactive inotrope score at 72 h following cardiac transplantation